Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Chiricozzi

Showing results (21-30 of 215) with videos related to

Pageof 22
Sort By:
Expert Opinion on Drug Safety|August 25, 2016
No meaningful association between suicidal behavior and the use of IL-17A-neutralizing or IL-17RA-blocking agentsAndrea Chiricozzi, Marco Romanelli, Rosita Saraceno, et al.
Acta Dermato-Venereologica|August 19, 2009
Urticaria associated with hyper-IgE in a patient with psoriasis undergoing treatment with efalizumabRosita Saraceno, Gea Scotto, Andrea Chiricozzi, et al.
Dermatologic Therapy|May 31, 2022
Successful treatment with secukinumab in an HIV-positive psoriatic patient after failure of apremilastPaolo Romita, Caterina Foti, Gianluca Calianno, et al.
Vaccines|December 5, 2020
The Risk of COVID-19 Pandemic in Patients with Moderate to Severe Plaque Psoriasis Receiving Systemic TreatmentsPaolo Gisondi, Francesco Bellinato, Andrea Chiricozzi, et al.
Dermatologic Therapy|August 29, 2022
Successful use of anti-IL-23 molecules in overweight-to-obese psoriatic patients: A multicentric retrospective studyFederica Ricceri, Andrea Chiricozzi, Ketty Peris, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|September 20, 2018
Isotretinoin-triggered acne fulminans: a rare, disabling occurrenceBruno Gualtieri, Salvatore Panduri, Andrea Chiricozzi, et al.
Skin Research and Technology : Official Journal of International Society for Bioengineering and the Skin (ISBS) [And] International Society for Digital Imaging of Skin (ISDIS) [And] International Society for Skin Imaging (ISSI)|December 20, 2011
Emerging applications of nanomedicine in dermatologyRosita Saraceno, Andrea Chiricozzi, Massimo Gabellini, et al.
Molecular Diagnosis & Therapy|October 1, 2013
Genetic markers for cardiovascular disease in psoriasis: the missing pieceTiago Torres, Andrea Chiricozzi, Sergio Chimenti, et al.
Vaccines|December 19, 2020
Immune Response to Vaccination in Patients with Psoriasis Treated with Systemic TherapiesAndrea Chiricozzi, Paolo Gisondi, Francesco Bellinato, et al.
Psoriasis (Auckland, N.Z.)|June 20, 2019
Emerging treatment options for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis: evaluating bimekizumab and its therapeutic potentialAndrea Chiricozzi, Clara De Simone, Barbara Fossati, et al.
Pageof 22

Showing results (21-30 of 215) with videos related to

Sort By:
Pageof 22
Expert Opinion on Drug Safety|August 25, 2016
No meaningful association between suicidal behavior and the use of IL-17A-neutralizing or IL-17RA-blocking agentsAndrea Chiricozzi, Marco Romanelli, Rosita Saraceno, et al.
Acta Dermato-Venereologica|August 19, 2009
Urticaria associated with hyper-IgE in a patient with psoriasis undergoing treatment with efalizumabRosita Saraceno, Gea Scotto, Andrea Chiricozzi, et al.
Dermatologic Therapy|May 31, 2022
Successful treatment with secukinumab in an HIV-positive psoriatic patient after failure of apremilastPaolo Romita, Caterina Foti, Gianluca Calianno, et al.
Vaccines|December 5, 2020
The Risk of COVID-19 Pandemic in Patients with Moderate to Severe Plaque Psoriasis Receiving Systemic TreatmentsPaolo Gisondi, Francesco Bellinato, Andrea Chiricozzi, et al.
Dermatologic Therapy|August 29, 2022
Successful use of anti-IL-23 molecules in overweight-to-obese psoriatic patients: A multicentric retrospective studyFederica Ricceri, Andrea Chiricozzi, Ketty Peris, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|September 20, 2018
Isotretinoin-triggered acne fulminans: a rare, disabling occurrenceBruno Gualtieri, Salvatore Panduri, Andrea Chiricozzi, et al.
Skin Research and Technology : Official Journal of International Society for Bioengineering and the Skin (ISBS) [And] International Society for Digital Imaging of Skin (ISDIS) [And] International Society for Skin Imaging (ISSI)|December 20, 2011
Emerging applications of nanomedicine in dermatologyRosita Saraceno, Andrea Chiricozzi, Massimo Gabellini, et al.
Molecular Diagnosis & Therapy|October 1, 2013
Genetic markers for cardiovascular disease in psoriasis: the missing pieceTiago Torres, Andrea Chiricozzi, Sergio Chimenti, et al.
Vaccines|December 19, 2020
Immune Response to Vaccination in Patients with Psoriasis Treated with Systemic TherapiesAndrea Chiricozzi, Paolo Gisondi, Francesco Bellinato, et al.
Psoriasis (Auckland, N.Z.)|June 20, 2019
Emerging treatment options for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis: evaluating bimekizumab and its therapeutic potentialAndrea Chiricozzi, Clara De Simone, Barbara Fossati, et al.
Pageof 22